InMode

Company Overview

Snapshot

Founded in January 2008 by Moshe Mizrahy, InMode is a public company with over 500 employees. The company has raised $70 million across one funding round and went public on NASDAQ in August 2019. In July 2023, InMode expanded its women's health and wellness market footprint through the acquisition of Viveve patents.

Business overview

InMode is a global provider of energy-based minimally invasive and noninvasive aesthetic solutions within the Health Tech & Life Sciences sector. The company develops and commercializes products utilizing medically accepted radio-frequency (RF) energy technology, designed to penetrate deep into the subdermal fat layer for adipose tissue remodeling. Its technologies are used by physicians for procedures such as liposuction with simultaneous skin tightening, face and body contouring, and ablative skin rejuvenation treatments, serving clinics and doctors in the medical devices industry.

Strategic signal

InMode's Board of Directors announced a share repurchase program of up to 7.68 million shares in September 2024. This strategic move signals a commitment to enhancing shareholder value and reflects confidence in the company's financial health and future prospects, potentially indicating a belief that the stock is undervalued.

Company Intelligence Q&A

When did InMode go public?

InMode went public on NASDAQ in August 2019.

What was InMode's most recent acquisition?

In July 2023, InMode expanded its women's health and wellness market footprint through the acquisition of Viveve patents.

What was the company's latest strategic financial move?

In September 2024, InMode announced a share repurchase program of up to 7.68 million shares, approved by its Board of Directors.

What was InMode's Q3 2024 earnings highlight?

In October 2024, InMode's Q3 2024 earnings call highlighted the company navigating challenges with strategic adjustments and seeing revenue growth.

What is InMode's financial outlook for Q3 2025?

In October 2025, InMode announced it expects Q3 2025 revenue to be between $92.5 million and $93.0 million, reiterating its full-year 2025 guidance of $365 million to $375 million.